Medicine, Endocrinology Division

Grants

Grants per year 1999 2009 2012 2016 2026

• 59 Active
• 310 Finished

Grants per year

Search results

• Finished

  Adaptation and Integration of a Telehealth Diabetes Discharge Toolkit for the COVID-19 Era

  Wallia, A.

  University of Chicago, National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/20 → 7/31/21

  Project: Research project

  • Telemedicine 100%
  • Patient Transfer 62%
  • Self-Directed Learning 40%
  • Transitional Care 37%
  • Education 33%

• Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial)

  Ahmad, F., Pandit, J. A. & Wallia, A.

  Duke University, Patient-Centered Outcomes Research Institute

  4/1/20 → 1/31/21

  Project: Research project

• Emergency funds critical to support diabetes clinics in providing essential medical care to vulnerable T1D populations impacted by the COVID-19 pandemic

  Aleppo, G.

  Leona M. and Harry B. Helmsley Charitable Trust

  4/1/20 → 9/30/21

  Project: Research project

  • Financial Management 100%
  • Pandemics 92%
  • Vulnerable Populations 90%
  • Telemedicine 72%
  • Emergencies 67%

• Epidemiology of Diabetes Interventions and Complications (EDIC)

  Wallia, A. & El Muayed, M.

  Case Western Reserve University, National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/19 → 6/30/20

  Project: Research project

  • National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 100%
  • Diabetes Complications 82%
  • Epidemiology 64%
  • DNA 34%

• Preventing Early Renal Loss Follow-up Study (PERLage)

  Molitch, M. E.

  Joslin Diabetes Center, Inc., JDRF International

  5/16/19 → 10/31/20

  Project: Research project

• Prot# I8B-MC-ITRO: A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion PRONTO-Pump-2

  Aleppo, G.

  Lilly USA, LLC

  4/25/19 → 10/15/21

  Project: Research project

• A Pilot Study to Assess the Effectiveness of Direct to Patient Initiation of CGM in Type I Diabetes

  Aleppo, G.

  Jaeb Center for Health Research

  2/1/19 → 9/30/19

  Project: Research project

  • diabetes 100%
  • chronic illness 78%
  • protocol 65%
  • study materials 49%
  • participation 41%

• Prot# OOC-ACM-303: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Octreotide Capsules in Patients Who Previously Tolerated and Demonstrated Biochemical Control on Injectable Somatostatin Recep

  Molitch, M. E.

  Pharm-Olam International Ltd., Chiasma, Inc.

  7/6/18 → 7/6/21

  Project: Research project

• Prot#NN9536-4373: Effect and Safety of Semaglutide 2.4 mg Once-Weekly in Subjects with Overweight or Obesity

  Neff, L. M. & Kushner, R. F.

  DrugDev Inc., Novo Nordisk Inc.

  6/29/18 → 6/29/21

  Project: Research project

• Vitamin D and Type 2 Diabetes (D2d)

  Neff, L. M. & Hahr, A. J.

  Tufts Medical Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases

  6/25/18 → 5/31/20

  Project: Research project

  • Prediabetic State 100%
  • Ergocalciferols 81%
  • Vitamin D 72%
  • Type 2 Diabetes Mellitus 58%
  • Placebos 26%

• Prot# NN9536-4374: Effect and Safety of Semaglutide 2.4 mg Once-Weekly in Subjects with Overweight or Obesity and Type 2 Diabetes

  Neff, L. M. & Kushner, R. F.

  DrugDev Inc., Novo Nordisk Inc.

  6/25/18 → 6/25/21

  Project: Research project

• Prot#COR-2017-01:A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open-label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

  Huang, W. & Molitch, M. E.

  Chiltern International, Inc., Cortendo AB (publ)

  4/24/18 → 4/24/21

  Project: Research project

• Trial ID: NN1218-4113 Efficacy and Safety of Fast-acting Insulin Aspart Compared to NovoRapid® both in Combination with Insulin Degludec with or without Metformin in Adults with Type 2 Diabetes (onset® 9)

  Aleppo, G.

  DrugDev Inc., Novo Nordisk Inc.

  10/2/17 → 10/2/20

  Project: Research project

• PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D

  Molitch, M. E., Batlle, D. & Wallia, A.

  Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases

  9/15/17 → 6/30/19

  Project: Research project

  • Telecommunications 100%
  • Allopurinol 91%
  • National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 59%
  • Multicenter Studies 47%
  • Clinical Trials 47%

• PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive Platform

  Woodruff, T. K., Kim, J. J., Urbanek, M. & Weiss, E. L.

  National Institute of Environmental Health Sciences

  9/1/17 → 8/31/19

  Project: Research project

• Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Cohort

  Molitch, M. E. & Wallia, A.

  Case Western Reserve University, National Institute of Diabetes and Digestive and Kidney Diseases

  7/5/17 → 6/30/20

  Project: Research project

• Wireless Innovation for Seniors with Diabetes Mellitus (WISDM)

  Aleppo, G.

  Jaeb Center for Health Research, JDRF International and The Leona M. and Harry B. Helmsley Charitable Trust

  7/1/17 → 12/31/20

  Project: Research project

• EDIC Skeletal Health Study

  Molitch, M. E.

  Case Western Reserve University, National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/17 → 6/30/19

  Project: Research project

• EDIC Hypoglycemia-Arrhythmia Study

  Molitch, M. E.

  Case Western Reserve University, National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/17 → 6/30/19

  Project: Research project

• Epidemiology of Diabetes Interventions and Complications (EDIC)

  Molitch, M. E. & Wallia, A.

  Case Western Reserve University, National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/17 → 6/30/19

  Project: Research project

  • Diabetes Complications 100%
  • Epidemiology 58%
  • C-Peptide 20%
  • Neurologic Examination 19%
  • Hypercholesterolemia 18%

• Study to Assess Predictive Value of CGM for Microvascular Complications of Diabetes

  Molitch, M. E.

  Joslin Diabetes Center, Inc., Leona M. and Harry B. Helmsley Charitable Trust

  7/1/17 → 9/30/19

  Project: Research project

• Home sleep and circadian phase: mediators of racial disparities in diabetes risk

  Knutson, K. L., Aleppo, G. & Abbott, S. M.

  National Institute of Diabetes and Digestive and Kidney Diseases

  6/22/17 → 9/30/19

  Project: Research project

  • Sleep 100%
  • African Americans 77%
  • European Continental Ancestry Group 47%
  • National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 16%
  • Health 15%

• Morning Light Treatment at Home to Improve Glucose Metabolism in People at Increased Risk for Type 2 Diabetes

  Knutson, K. L. & Aleppo, G.

  National Institute of Nursing Research

  6/1/17 → 11/30/19

  Project: Research project

  • Light 100%
  • Glucose 73%
  • Prediabetic State 66%
  • Type 2 Diabetes Mellitus 65%
  • Melatonin 27%

• Regulation of glucose and lipid metabolism by the transcriptional repressor BCL6 in liver

  Barish, G. D., Bass, J. & Green, R.

  American Diabetes Association

  1/1/17 → 12/31/19

  Project: Research project

  • Lipid Metabolism 100%
  • Glucose 93%
  • Type 2 Diabetes Mellitus 75%
  • Liver 68%
  • Lipids 65%

• Multiethnic Fine-Mapping of Polycystic Ovary Syndrome Susceptibility Loci

  Dunaif, A. E., Hayes, M. G. & Urbanek, M.

  National Institute of Child Health and Human Development

  9/30/16 → 6/30/17

  Project: Research project

  • Polycystic Ovary Syndrome 100%
  • LH Receptors 17%
  • Genetic Loci 16%
  • Follicle Stimulating Hormone 14%
  • Chorionic Gonadotropin 14%